SFPIA
STML

Stevens First Principles Investment Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-600
Closed -$27K – 231
2013
Q3 		$27K Buy
+600
New +$19.6K 0.02% 154

Other funds holding STML

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Stevens First Principles Investment Advisors's STML Position: Q4 2013 in Review

Stevens First Principles Investment Advisors sold out of Stemline Therapeutics, Inc. (STML) in Q4 2013, closing a stake of 600 shares — an estimated $27K sold.

Stevens First Principles Investment Advisors first reported a position in STML in Q3 2013 and held it in 1 quarter. The position peaked at $27K in Q3 2013. 69 funds tracked by Wall St. Rank hold STML as of Q4 2013.

  • Stevens First Principles Investment Advisors reported no remaining Stemline Therapeutics, Inc. position as of Q4 2013 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 600 Stemline Therapeutics, Inc. shares in Q4 2013, an estimated $27K.
  • Stevens First Principles Investment Advisors first reported a position in Stemline Therapeutics, Inc. in Q3 2013 and held it in 1 quarter.
  • Stevens First Principles Investment Advisors's Stemline Therapeutics, Inc. position peaked at $27K in Q3 2013.
  • 69 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q4 2013.

Based on Stevens First Principles Investment Advisors's 13F filing for Q4 2013, filed 7 Feb 2014.